6.79k 個跟隨者 • 31 個股票代號 追蹤清單由 Yahoo Finance 提供
尋找列有沽空股份總額最多熱門股票的清單。探索你想交易和投資的股票。
RKT8.02-0.11%
Rocket Companies, Inc.
AI40.01-3.94%
C3.ai, Inc.
HELE96.28-2.13%
Helen of Troy Limited
CVNA12.92-0.80%
Carvana Co.
UPST27.24-1.85%
Upstart Holdings, Inc.
CNK16.01-0.07%
Cinemark Holdings, Inc.
MARA9.790.37%
Marathon Digital Holdings, Inc.
SLG23.130.20%
SL Green Realty Corp.
EVGO3.96-0.03%
EVgo, Inc.
ASTS5.42-0.02%
AST SpaceMobile, Inc.
SAVA22.71-0.09%
Cassava Sciences, Inc.
TRUP22.471.19%
Trupanion, Inc.
TWST15.15-0.04%
Twist Bioscience Corporation
MVIS4.690.23%
MicroVision, Inc.
PACW6.45-0.38%
西太平洋銀行公司
ALLO5.250.06%
Allogene Therapeutics, Inc.
NVAX8.050.62%
Novavax, Inc.
BYND10.15-0.15%
Beyond Meat, Inc.
EDIT9.180.22%
Editas Medicine, Inc.
FATE5.050.09%
Fate Therapeutics, Inc.
VTNR6.470.06%
Vertex Energy, Inc.
ARQT7.51-0.30%
Arcutis Biotherapeutics, Inc.
BLNK6.73-0.17%
Blink Charging Co.
LOVE21.08-0.11%
The Lovesac Company
VUZI5.02-0.14%
Vuzix Corporation
PLCE15.03-1.27%
The Children's Place, Inc.
BIG5.02-0.38%
Big Lots, Inc.
RAD1.79-
Rite Aid Corporation
XELA5.150.42%
Exela Technologies, Inc.
HCDI3.850.01%
Harbor Custom Development, Inc.
Reallocate costs. Unwind charges. Delay depreciation. Companies are using nontraditional ways to boost the bottom line as slowing business makes it harder to meet earnings expectations.
(Bloomberg) -- C3.ai Inc. plunged 20% in extended trading after providing a fiscal-year revenue outlook that fell short of analysts’ estimates, fueling concerns the artificial intelligence software company is not living up to the investor enthusiasm that has seen its stock price more than triple this year.Most Read from BloombergChina Is Drilling a 10,000-Meter-Deep Hole Into Earth’s CrustS&P 500 Almost Wipes Out Its Monthly Advance: Markets WrapDebt-Limit Deal Wins House Passage, Easing US Defa
The electric vehicle boom isn’t just about passenger cars and trucks, it’s also about the millions of speedboats and other recreational boats
C3.ai, Inc. (AI) delivered earnings and revenue surprises of 23.53% and 0.12%, respectively, for the quarter ended April 2023. Do the numbers hold clues to what lies ahead for the stock?
C3.ai issued a full-year fiscal 2024 revenue outlook that missed analyst estimates, sending AI stock tumbling in late trade Wednesday.
The AI stock tumbled after the company's fiscal year earnings outlook fell shy of Wall Street estimates.
C3.ai had sales of $72.4 million in the fiscal fourth quarter--in line with the higher end of its preliminary sales numbers.
Yahoo Finance Live breaks down some of the biggest stock movers in after-hours trading.
C3.ai posted better than expected fourth quarter earnings on Wednesday, but shares of the company fell more than 12% in after hours trading.
REDWOOD CITY, Calif., May 31, 2023--C3.ai, Inc. (NYSE: AI), the Enterprise AI application software company, today announced financial results for its fiscal fourth quarter and full fiscal year ended April 30, 2023.
As chipmaker Nvidia soars above a $1 trillion market value, investors are searching for the next big tech name that could see the same AI boost. Portfolio Manager of the BullseyeBrief.com American Ingenuity Fund Adam Johnson details several tech stocks that could follow Nvidia's lead and capitalize on artificial intelligence trends.
Carvana stock shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 69 to 88.
There was no news out on the volatile AI stock, but its fiscal fourth-quarter earnings report is due out after hours today, and investors seem to be positioning themselves ahead of the report, with some investors taking profits after yesterday's pop. An earlier attack by short-seller Kerrisdale Capital had sent the stock spiraling, but C3.ai seemed to put the charges behind it after that announcement. Additionally, Nvidia's (NASDAQ: NVDA) blowout guidance in its earnings report last week stoked another round of enthusiasm for AI stocks, with C3.ai rallying once again.
Investing.com -- C3.Ai reported fiscal fourth-quarter results Wednesday that were better than feared as growing demand for enterprise AI applications bolstered new business wins.
Sanofi's (SNY) phase II study on its novel investigational anti-CD40L antibody, frexalimab, meets the primary endpoint.
J&J (JNJ) submits a new drug application for a single tablet combination therapy of macitentan and tadalafil for the long-term treatment of pulmonary arterial hypertension.
The regulator said thousands of banks lost $472 billion in deposits during the first quarter, the biggest drop since it began collecting such data in 1984.
Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, announced today that it has partnered with TeamOpenSmartGlasses ("TOSG") to develop ChatGPT AI applications on Vuzix smart glasses. Under development are a suite of conversation enhancement tools built for all-day wearable smart glasses. These apps improve meetings and conversations with live info that enhances user understanding of conversations
Congress' draft debt-ceiling bill doesn't include a heavy crypto tax that the White House had proposed.
PHOENIX, May 31, 2023--Carvana (NYSE: CVNA), an industry pioneer for buying and selling cars online, is recognized by Forbes as one of the Best Employers for Diversity in 2023. Carvana is the largest online used car dealer in the United States, employing thousands of people representing a variety of perspectives and cultural backgrounds. This recognition lands on the heels of Carvana’s recent designation by the publication as one of America’s Best Employers, and celebrates the work of its leader
SAN DIEGO, May 31, 2023 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders, today announced that the Company will participate in the following upcoming investor conferences: 2023 Jefferies Healthcare Conference on Wednesday, June 7, 2023 a
SOUTH SAN FRANCISCO, Calif., May 31, 2023--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and CeGaT GmbH, a global provider of sequencing services for research, clinical studies, and human genetic diagnostics, today announced the launch of the Twist Alliance CeGaT RNA Fusion Panel, which is designed to detect RNA fusions and conduct transcript variant analysis for oncology researc
Earlier this year KuCoin closed a $10 million funding round into CNHC.
A look at the stocks making headlines on Wednesday.
While this is most often associated with biotech companies that could be a hit or fade away based on a regulatory decision, it's also been the reality for Upstart (NASDAQ: UPST). Upstart offers an alternative way to assess creditworthiness rather than a traditional FICO score and uses artificial intelligence (AI) to assess a loan applicant. The stock has plummeted more than 90% from its highs, although Upstart has rebounded in the past few months.